Identification and functional analysis of a KCNA5 mutation responsible for idiopathic atrial fibrillation

National Medical Journal of China

Volumn 90, Issue 16, 2010, Pages 1100-1104

  Yang, Yi Qing ^a   Lin, Xiao Ping ^b   Li, Jun ^b   Chen, Yi Han ^b  

^a SHANGHAI CHEST HOSPITAL   (China)

^b NONE

Author keywords

Atrial fibrillation; Gene; KCNA5; Mutation

Indexed keywords

LIPOFECTAMINE; POTASSIUM CHANNEL KV1.5; KCNA5 PROTEIN, HUMAN;

ARTICLE; BLOOD SAMPLING; CELLULAR DISTRIBUTION; CLINICAL EVALUATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EXON; GENE AMPLIFICATION; GENE MUTATION; GENETIC TRANSFECTION; HEART ATRIUM FIBRILLATION; HUMAN; IDIOPATHIC DISEASE; INTRON; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOLECULAR CLONING; MUTAGENESIS; PATCH CLAMP; POINT MUTATION; POLYMERASE CHAIN REACTION; ADULT; AGED; CASE CONTROL STUDY; FEMALE; GENETICS; MALE; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY;

ADULT; AGED; ATRIAL FIBRILLATION; BASE SEQUENCE; CASE-CONTROL STUDIES; FEMALE; HUMANS; KV1.5 POTASSIUM CHANNEL; MALE; MIDDLE AGED; MUTATION;

EID: 84871408524     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.16.007     Document Type: Article

References (13)

1. Go A S, Hylek E M, Phillips K A, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 2001, 285: 2370-2375.
2. Lloyd-Jones D M, Wang T J, Leip E P, et al. Lifetime risk for development of atrial fibrillation: the framinham heart study. Circulation, 2004, 110: 1042-1046.
3. Wang T J, Larson M G, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the framingham heart study. Circulation, 2003, 107: 2920-2925.
4. Stewart S, Hart C L, Hole D J, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart, 2001, 86: 516-521.
5. Ellinor P T, Yoerger D M, Ruskin J N, et al. Familial aggregation in lone atrial fibrillation. Hum Genet, 2005, 118: 179-184.
6. Wiesfeld A C, Hemels M E, Van Tintelen J P, et al. Genetic aspects of atrial fibrillation. Cardiovasc Res, 2005, 67: 414-418.
7. Postma A V, Dekker L R, Soufan A T, et al. Developmental and genetic aspects of atrial fibrillation. Trends Cardiovasc Med, 2009, 19: 123-130.
8. Darbar D, Herron K J, Ballew J D, et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol, 2003, 41: 2185-2192.
9. Curran M E, Landes G M, Keating M T. Molecular cloning, characterization, and genomic localization of a human potassium channel gene. Genomics, 1992, 12: 729-737.
10. Kwak Y G, Hu N, Wei J, et al. Protein kinase A phosphorylation alters Kv beta1.3 subunit-mediated inactivation of the Kv1.5 potassium channel. J Biol Chem, 1999, 274: 13928-13932.
11. + current in cultured adult human atrial myocytes. Circ Res, 1997, 80: 572-579.
12. Fedida D, Eldstrom J, Hesketh JC, et al. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes. Circ Res, 2003, 93: 744-751.
13. Olson T M, Alekseev A E, Liu X K, et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet, 2006, 15: 2185-2191.